Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEucrates Biomedical Acquisition Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/13/2023 | Q4 2022 | $0.18 | $0 | |||
| 11/14/2022 | Q3 2022 | $0.09 | $0 | |||
| 08/15/2022 | Q2 2022 | $0.07 | $0 | |||
| 05/23/2022 | Q1 2022 | $0.21 | $0 | |||
| 04/08/2022 | Q4 2021 | $0.69 | $0 | |||
| 11/22/2021 | Q3 2021 | $0.32 | $0 | |||
| 08/16/2021 | Q2 2021 | $0.15 | $0 | |||
| 07/16/2021 | Q1 2021 | $0.45 | $0 | |||
| 03/31/2021 | Q4 2020 | $0.00 | $0 |
Eucrates Biomedical Acquisition Corp. Earnings: FAQ's
When is Eucrates Biomedical Acquisition Corp.'s earnings date?
Eucrates Biomedical Acquisition Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 30th, 2022 based off last year's report dates.
How can I listen to Eucrates Biomedical Acquisition Corp.'s earnings conference
call?
The conference call for Eucrates Biomedical Acquisition Corp.'s latest earnings report can be listened to online.
How can I read Eucrates Biomedical Acquisition Corp.'s conference call transcript?
The conference call transcript for Eucrates Biomedical Acquisition Corp.'s latest earnings report can be read online.
How much profit does Eucrates Biomedical Acquisition Corp. generate each year?
Eucrates Biomedical Acquisition Corp. (:EUCRU) has a recorded net income of $0. Eucrates Biomedical Acquisition Corp. has generated $1.86 earnings per share over the last four quarters.
What is Eucrates Biomedical Acquisition Corp.'s price-to-earnings ratio?
Eucrates Biomedical Acquisition Corp. (:EUCRU) has a price-to-earnings ratio of 5.4 and price/earnings-to-growth ratio is 0.05.